Luuk Gras

European Society for Blood and Marrow Transplantation — Netherlands

Immunology and Microbiology · Life Sciences

33h-index5.0kcitations101works2.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(41), HIV/AIDS drug development and treatment(38), HIV/AIDS Research and Interventions(35), HIV-related health complications and treatments(16), Chronic Myeloid Leukemia Treatments(13)

Publications100 total

Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Bone Marrow Transplantation·2025Open Access
A comparison of cryopreserved and noncryopreserved peripheral blood hematopoietic stem cells for autologous transplantation in multiple myeloma: a study from the chronic malignancies working party of the EBMT
Cytotherapy·2025
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Bone Marrow Transplantation·2024· 3 cited
Prediction of Poor Survival after Hematopoietic Cell Transplantation in Myelofibrosis Using Machine Learning Techniques
Blood·2024· 1 citedOpen Access
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Study on Behalf of the Chronic Malignancies Working Party of the EBMT
Blood·2024· 2 citedOpen Access
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (<scp>WBMT</scp>)
American Journal of Hematology·2024· 9 citedOpen Access
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT
British Journal of Haematology·2024· 3 citedOpen Access
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Haematologica·2024· 4 citedOpen Access
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Haematologica·2024· 1 citedOpen Access
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the <scp>EBMT</scp>
British Journal of Haematology·2023Open Access
Outcomes of <scp>CMML</scp> patients undergoing <scp>allo‐HCT</scp> are significantly worse compared to <scp>MDS</scp>—a study of the <scp>CMWP</scp> of the <scp>EBMT</scp>
American Journal of Hematology·2023· 4 citedOpen Access
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT
Bone Marrow Transplantation·2023· 10 citedOpen Access
Conditioning Intensity in Patients Aged &amp;gt; 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
Blood·2023Open Access
A Randomized Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study)
Clinical Infectious Diseases·2023· 5 citedOpen Access
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Transplantation and Cellular Therapy·2023· 7 citedOpen Access
Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature
Bone Marrow Transplantation·2023
Sequential vs Myeloablative vs Reduced Intensity Conditioning for Patients with Myelodysplastic Syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: A Retrospective Study by the Chronic Malignancies Working Party of the EBMT
2023Open Access
Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—The DIADEM study from the chronic malignancies working party of the EBMT
Bone Marrow Transplantation·2023· 9 citedOpen Access
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
American Journal of Hematology·2023· 20 citedOpen Access
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
Haematologica·2022· 14 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Peter Reiss(23), Ard van Sighem(12), Jan M. Prins(11), Marc van der Valk(9), Frank de Wolf(8), Jens Lundgren(8), Kees Brinkman(7), Caroline Sabin(7), Ruth Gilbert(7), Frank de Wolf(7), Jan T. M. van der Meer(6), Christophe Fraser(6), Antonella d’Arminio Monforte(6), Colette Smith(6), Ferdinand W.N.M. Wit(5), Suzanne E. Geerlings(5), Maria Prins(5), Daniela Bezemer(5), Anouk M Kesselring(5), Matthew Law(5)